Show simple item record

dc.contributor.authorArslan, S.
dc.contributor.authorDogan, Z.
dc.contributor.authorKucukazman, M.
dc.contributor.authorPoyrazoglu, O. K.
dc.contributor.authorBiyik, M.
dc.contributor.authorOzturk, N. A.
dc.contributor.authorAydogan, T.
dc.contributor.authorCoban, S.
dc.contributor.authorKocaman, O.
dc.contributor.authorSapmaz, F.
dc.contributor.authorGokturk, S. H.
dc.contributor.authorDemirezer, A.
dc.contributor.authorTanoglu, A.
dc.contributor.authorYildirim, B.
dc.contributor.authorAltinbas, A.
dc.contributor.authorAtak, B. M.
dc.contributor.authorCosar, A. M.
dc.contributor.authorAlkan, E.
dc.contributor.authorKOÇAK TUFAN, ZELİHA
dc.contributor.authorKekilli, M.
dc.contributor.authorAtaseven, H.
dc.contributor.authorPurnak, T.
dc.contributor.authorBasar, O.
dc.contributor.authorKoklu, N.
dc.contributor.authorOzturk, O.
dc.contributor.authorKaraca, C.
dc.contributor.authorBesisik, F.
dc.contributor.authorUnverdi, S.
dc.contributor.authorGuner, R.
dc.contributor.authorBakkaloglu, K.
dc.contributor.authorKoklu, S.
dc.contributor.authorGulsen, M. T.
dc.contributor.authorTuna, Y.
dc.contributor.authorKoklu, H.
dc.contributor.authorYuksel, O.
dc.contributor.authorDemir, M.
dc.contributor.authorKockar, C.
dc.date.accessioned2021-03-05T11:56:53Z
dc.date.available2021-03-05T11:56:53Z
dc.date.issued2015
dc.identifier.citationKoklu S., Gulsen M. T. , Tuna Y., Koklu H., Yuksel O., Demir M., Guner R., Dogan Z., Kucukazman M., Poyrazoglu O. K. , et al., "Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B", ALIMENTARY PHARMACOLOGY & THERAPEUTICS, cilt.41, ss.310-319, 2015
dc.identifier.issn0269-2813
dc.identifier.othervv_1032021
dc.identifier.otherav_aaa927d5-0868-4427-a08c-16f41a5aa1a4
dc.identifier.urihttp://hdl.handle.net/20.500.12627/113965
dc.identifier.urihttps://doi.org/10.1111/apt.13036
dc.description.abstractBackgroundResults are conflicting with respect to the renal effects of anti-viral agents used for hepatitis B virus infection.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleDifferences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B
dc.typeMakale
dc.relation.journalALIMENTARY PHARMACOLOGY & THERAPEUTICS
dc.contributor.departmentHacettepe Üniversitesi , ,
dc.identifier.volume41
dc.identifier.issue3
dc.identifier.startpage310
dc.identifier.endpage319
dc.contributor.firstauthorID221063


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record